Correlations between complex IV markers (complex IV expression, complex IV activity, COX-IV expression) and cytochrome c expression in tumor-bearing mice receiving either isotype control (IgG2a) or anti-PD-1 (aPD-1) treatment. This evidence concerns the gene CYCS and neoplasm.